The of aquatic exercise interventions on quality of sleep, mental toughness, cognitive function, fatigue, paresthesia and depression among patients with Multiple Sclerosis (MS)

The effect and non- effect of aquatic exercise interventions on quality of sleep, mental toughness, cognitive function, fatigue, paresthesia and depression among patients with Multiple Sclerosis (MS) (Clinical trial study with control group)

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20150822023705N9

Enrollment

Registered

2018-07-07

Start date

2018-08-23

Completion date

Unknown

Last updated

2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MS. Multiple sclerosis

Interventions

Intervention 1: Intervention group: The experimental group will perform an aquatic exercise in 8 weeks and in every week 3 sessions of 60 minutes that will be conducted under a trained and professiona

Eligibility

Sex/Gender

Female

Age

18 Years to 56 Years

Inclusion criteria

Inclusion criteria: Diagnosis of MS by neurologist; Female gender; Age 18-65 years; EDSS 0-6; No diagnosed cardiovascular diseases; No metabolic disorders; Psychiatric disorders and orthopedically diseases; No comorbid with other neurological diseases ; Willing and able to comply with the study conditions; Written informed consent.

Exclusion criteria

Exclusion criteria: Male gender; Unable or unwilling to adhere to the study intervention of more than 70% and MS relapse during interference

Design outcomes

Primary

Measure	Time frame
Fatigue. Timepoint: The beginning of the study (baseline), week four and end of the study (week eight). Method of measurement: Fatigue Severity Scale (FSS).;Depression. Timepoint: The beginning of the study (baseline), week four and end of the study (week eight). Method of measurement: Beck Depression Inventory (BDI).;Mental toughness. Timepoint: The beginning of the study (baseline), week four and end of the study (week eight). Method of measurement: Mental toughness questionnaire (MTQ48).;Quality of sleep. Timepoint: The beginning of the study (baseline), week four and end of the study (week eight). Method of measurement: Insomnia Severity Index (ISI).;Paresthesia. Timepoint: The beginning of the study (baseline), week four and end of the study (week eight). Method of measurement: Visual Analogue Scale(VAS).;Neurological performance. Timepoint: The beginning of the study (baseline), week four and end of the study (week eight). Method of measurement: StroopTest and NUCog test.	—

Measure

Time frame

Fatigue. Timepoint: The beginning of the study (baseline), week four and end of the study (week eight). Method of measurement: Fatigue Severity Scale (FSS).;Depression. Timepoint: The beginning of the study (baseline), week four and end of the study (week eight). Method of measurement: Beck Depression Inventory (BDI).;Mental toughness. Timepoint: The beginning of the study (baseline), week four and end of the study (week eight). Method of measurement: Mental toughness questionnaire (MTQ48).;Quality of sleep. Timepoint: The beginning of the study (baseline), week four and end of the study (week eight). Method of measurement: Insomnia Severity Index (ISI).;Paresthesia. Timepoint: The beginning of the study (baseline), week four and end of the study (week eight). Method of measurement: Visual Analogue Scale(VAS).;Neurological performance. Timepoint: The beginning of the study (baseline), week four and end of the study (week eight). Method of measurement: StroopTest and NUCog test.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNazanin Razazian

Kermanshah University of Medical Sciences

RAZAZIAN@Gmail.com+98 83 3826 4513

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026